Objectives-Elcatonin (eCT
tion of these substances were studied. Results-Baseline production of IgM, ILla and IL-1, by MNCs/monocytes in the eCT and NV groups was significantly lower than that in the NSAID group. Furthermore, addition of eCT to the culture medium significantly inhibited the productions of IgG, IgMRF, IL-lot and IL-1" by MNCs/monocytes in the NSAID group, whereas production of neither IgG, IgA, IgM, IgMRF nor IL-1 by MNCs/monocytes in the PSL and NV groups was affected by eCT. Conclusion-eCT may regulate immune responses through MNC/monocyte function in patients with RA. The present results support our proposal that eCT is an effective agent for the treatment of RA. (Ann Rheum Dis 1994; 53: 247-249) Calcitonin (CT), a hormone produced in the thyroid gland, is widely known to inhibit bone resorption by osteoclasts,1-3 and has been used for treatment of osteoporosis. In patients with rheumatoid arthritis (RA), however, we have demonstrated that treatment with elcatonin (eCT), an eel CT derivative, considerably improved not only the clinical signs and symptoms but also decreased the erythrocyte sedimentation rate (ESR), and the serum levels of C-reactive protein (CRP), IgG, IgA, IgM and IgM-rheumatoid factor (IgMRF). Furthermore, the efficacy of eCT was suggested to be altered by preceding and/or concomitant use of corticosteroid. 4 5 In this study we investigated the effects of eCT on production of IgG, IgA, IgM, IgMRF by cultured mononuclear cells (MNC)s, as well as production of IL-lao and IL-iI3 by monocytes.
Patients and methods
Twenty nine patients with RA6 and 10 normal volunteers were studied after obtaining their informed consent. Ten patients with RA, as controls, had been treated with a non-steroidal anti-inflammatory drug (NSAID) only, although the type of drug and its dose varied (NSAID group, nine women, one man; mean age, 61 years; mean stage [7] , 1 7). Eleven patients with RA had been treated additionally with oral prednisolone, 2-5-5-0 mg/day ( figs 3, 4) . In the PSL and NV groups, however, these suppressive effects of eCT on the production of immunoglobulins, IgMRF and cytokines by MNCs/monocytes were not significant (figs 3, 4).
Discussion
The present results showed that in vivo treatment with eCT inhibits the production of IgM (fig 1) , IL-lot and IL-13 ( fig 2) by MNCs/ monocytes obtained from patients with RA, and also that in vitro application of eCT inhibits the production of IgG, IgMRF (fig 3) , IL-lot and IL-i1 ( (fig 4) prednisolone. eCT concentration eCT concentration in medium (ng/ml) in medium (ng/ml) 101-32. 
